TrialCancer2015

Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea.

Yehua Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.